LPTX

Leap Therapeutics (LPTX)

About Leap Therapeutics (LPTX)

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

Details

Daily high
$3.00
Daily low
$2.75
Price at open
$2.76
52 Week High
$5.00
52 Week Low
$1.68
Market cap
111.5M
Dividend yield
0.00%
Volume
329,120
Avg. volume
446,322
P/E ratio
-1.51

Leap Therapeutics News

Details

Daily high
$3.00
Daily low
$2.75
Price at open
$2.76
52 Week High
$5.00
52 Week Low
$1.68
Market cap
111.5M
Dividend yield
0.00%
Volume
329,120
Avg. volume
446,322
P/E ratio
-1.51